Hydromer, Inc. Announces Preliminary Financial Results for Q2 2025

Hydromer, Inc. (OTC: HYDI), a pioneer in coating technologies for medical devices, has disclosed its preliminary, unaudited financial outcomes for the second quarter ending June 30, 2025. The company witnessed a revenue uptick to $0.94 million, marking a 14% rise from the $0.82 million recorded in the corresponding quarter of the previous year. However, the quarter also saw a net loss of $38,000, attributed to expenditures on legal and professional services, alongside upgrades to facilities and equipment.

Michael E. Torti, CEO of Hydromer, emphasized the quarter's results as a testament to the company's robust customer relationships and the pivotal role of its coating technologies in the medical device industry. Despite the financial setback, Torti views the incurred expenses as essential investments aimed at fostering innovation, expanding market reach, and enhancing future financial performance. The company's strategy focuses on developing its product pipeline, establishing new partnerships, and maintaining operational discipline.

Hydromer's commitment to innovation and scalability is unwavering, with a continued emphasis on operational efficiency, customer collaboration, and the advancement of next-generation technologies. For more information on Hydromer's technologies and services, visit https://www.hydromer.com.

The press release also includes forward-looking statements, cautioning readers about the uncertainties and risks that could influence future results. Hydromer advises against undue reliance on these projections, noting that actual outcomes may vary due to various factors. The company reserves the right to update these statements as necessary, in compliance with legal requirements.